Verdict

REMOVE from QQQ basket. Redistribute 0.38% weight across survivors.

WBD is not a stock anymore. It is a merger arbitrage spread trading at $27.07 against a $31.00 deal price. Expected excess return vs QQQ over 15 weeks is -7.9%. The asymmetry is unfixable: 10% deal-break probability contributes -5% to expected return all by itself. We have zero information edge against specialized arb desks on a $67B name with 20 analysts.

The Deal

Paramount Skydance (PSKY) signed a definitive merger agreement on February 27, 2026 at $31.00/share all-cash, plus a ticking fee of $0.00278/day if closing extends past September 30, 2026 (capped at $0.25/quarter). Larry Ellison personally guaranteed $45.72B of merger consideration. Reverse break fee: $7.0B. WBD termination fee: $3.0B plus up to $4.33B in PSKY reimbursements. The competing Netflix deal was terminated simultaneously, with PSKY paying the $2.8B termination fee on WBD's behalf.

Deal deadline: March 4, 2027, extendable to June 4, 2027. Our horizon: 15 weeks (~July 9, 2026). The deal almost certainly does not close within our window.

The Spread Is Widening

Current spread: 14.5%. Wide for a signed deal with a $7B break fee.

Stock is down 7.1% in the past month. RSI 32.8. The spread has widened, not narrowed, despite DOJ second request certification on February 9. Three regulatory headwinds have emerged post-signing:

1. DOJ/FCC "no fast-track." Despite clearing the second request, regulators are not expediting review. Extended timeline now baseline.

2. California AG Rob Bonta antitrust probe. State-level investigation focused specifically on labor impacts of the merger. This is a new vector not present in the original risk assessment.

3. WBD executive resistance. Politico reported on March 20 that WBD executives were in a "text chain" hoping Bonta blocks the deal over fear of post-merger layoffs. When your own management is rooting against your deal, that is information.

4. State lawsuits. Multiple state-level legal challenges adding friction.

Insiders sold $63M+ in March: Perrette ($18M), Gould ($16.4M), Wiedenfels ($28M). This is executives monetizing while they can, not a confidence signal.

Options: The Market's Probability Distribution

July 17, 2026 expiry (112 days, aligns with our window):

  • $31 call delta: 0.07 — market prices ≈7% probability stock reaches deal price by July
  • $30 call delta: 0.19 — ≈19% probability of meaningful spread compression
  • $23 put (61,162 OI): Deal-break insurance. Largest single position in the chain
  • P/C ratio: 2.50 — 104K puts vs 42K calls. Heavily bearish positioning
  • IV inversion: ATM calls at 56.9% vs ATM puts at 20.7%. Normally puts carry higher IV. This inversion means the market treats a jump to deal price as a tail event, with gradual drift/decline as the base case

April 17 expiry (360K OI, largest by far):

  • $31 call at $0.01, delta 0.01. The market gives approximately 1% probability of deal close within three weeks.
  • 100,506 puts at $27 strike. Massive ATM hedging.

The options chain is not ambiguous. Professional arb desks are long the stock and hedged with puts. The spread is their compensation for bearing deal-break risk. We have no reason to accept that risk for a 0.38% QQQ weight.

Scenario Math

Standalone value if deal breaks:

  • EBITDA $8.74B at 6x = $52.4B enterprise value
  • Less net debt $28.2B ($32.8B debt minus $4.57B cash) = $24.2B equity
  • 2.48B shares = ≈$9.76/share
  • Plus $7B reverse break fee = +$2.82/share = ≈$12.58/share
  • Deal break range: $10-18/share (-33% to -63% from current)

15-week expected return:

ScenarioProbabilityReturnContribution
Spread compresses (EU Phase 1 clears)20%+10%+2.0%
Spread flat (regulatory limbo)55%0%0.0%
Spread widens (CA AG escalation)15%-12.5%-1.9%
Deal breaks10%-50%-5.0%
Total-4.9%

Against QQQ expected return of ≈3%, the expected excess return is -7.9%.

The arithmetic is punishing. The deal-break scenario, even at only 10% probability, contributes -5% to expected return. The bull scenario at 20% probability only contributes +2%. You cannot make this work for a filtration strategy.

Edge Audit

Counterparty: specialized merger arb funds. Goldman, Citadel, Elliott, every arb desk that has been pricing media M&A for decades. They have the same filings, better regulatory intelligence, dedicated legal teams tracking state AG actions, and hedging infrastructure we do not have.

Information edge: zero. $67B market cap. 20 analysts (17 holds, showing the entire sell-side has collapsed to "wait and see"). Everything in this memo is public. We are not the informed party.

Factor decomposition: irrelevant. Pre-deal beta of 1.68 is noise. The stock trades on P(deal close) and the risk-free rate, not on sector rotation or style factors. Idio vol of 49.9% is deal-break risk, not exploitable alpha.

Horizon mismatch: fatal. The catalyst (deal close/break) resolves by March 2027 at earliest. We have 15 weeks. We would be holding merger arb exposure with no edge, no hedge, and no catalyst in our window. This is renting risk for no return.

The Business (If You Care)

Irrelevant for sizing, but for the record:

  • Revenue $37.3B (-5%), Adjusted EBITDA $8.74B (-3%)
  • Streaming: EBITDA +102% to $1.37B, 131.6M subscribers (+13%), but ARPU -11% (scale-before-monetize)
  • Linear: EBITDA -21%, structural decline management calls "expected to continue"
  • Studios: EBITDA +54% to $2.55B
  • FCF $3.1B, but $73.4B total obligations ($32.8B debt principal + $19.75B content + $10.7B interest)
  • $15B bridge loan maturity June 2027 — the gun at WBD's head making the deal existential
  • No going concern language (contractually required by both bridge loan and revolver covenants)
  • March 16 8-K: Zaslav tax reimbursement agreement (280G excise tax gross-up). Standard change-of-control executive comp, not deal-relevant.

The business generates real cash ($3.1B FCF) but is structurally transitioning from linear to streaming while carrying enormous leverage. Without the deal, this is a levered media turnaround. With the deal, it is someone else's problem at $31/share.

Decision

Remove WBD. The expected excess return is negative. The tail risk is catastrophic. We have no edge. The catalyst does not resolve in our window. This is merger arb, not filtration alpha, and we do not run a merger arb book.